Stem Cell Therapy Market
Stem Cell Therapy Market Size, Share & Trends Analysis Report, By Type (Allogeneic and Autologous), By Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, and Autoimmune & Inflammatory), By Cell Source (Adipose Tissues, Bone Marrow, and Placenta/Umbilical Cord), Forecast Period (2022-2028) Update Available - Forecast 2024-2030
Stem cell therapy market is anticipated to grow at a CAGR of 15.8% during the forecast period. The rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells are key factors driving the market. The rise in the demand for induced pluripotent stem cells (iPSCs) as an alternative to embryonic stem cells (ESCs) and the growing demand for cell & gene therapies are further expected to promote market growth. Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the body by reducing inflammation and modulating the immune system.
This phenomenon makes stem cell therapy a viable treatment option for a variety of medical conditions. The growing cases of CVD, autoimmune & inflammatory disorders are further creating demand for stem cell therapies. The growing awareness among the population regarding stem cell therapy through social media platforms is driving the market growth. The ethical concerns related to embryonic stem cells may restrain its market growth.
Impact of COVID-19 Pandemic on Global Stem Cell Therapy Market
Stem cell therapy was significantly increased during the COVID-19 pandemic. Companies are focusing on developing therapies for reducing different stress associated with COVID-19. For instance, in October 2020, NoveCite and Novellus Therapeutics Ltd. entered a partnership for developing & commercializing NoveCite iPSCs for treating COVID-19-associated acute respiratory distress syndrome (ARDS). The process has multimodal immunomodulatory mechanisms of action, which makes it a promising therapy for treating acute respiratory diseases.
Segmental Outlook
The global stem cell therapy market is segmented by type, therapeutic application, and cell source. The market segmentation based on the type includes allogeneic and autologous. Based on therapeutic application, the market is segmented into musculoskeletal, wound & injury, CVD, and autoimmune & inflammatory. Based on cell source, the market is segmented into adipose tissues, bone marrow, and placenta/umbilical cord. The allogeneic segment held a considerable share in the global stem cell therapy market. The ease of manufacturing & production processes and the increasing availability of novel stem cell products across major geographies is a key factors driving the growth of this market segment.
Regional Outlook
The global stem cell therapy market is further segmented based on geography including North America (the US and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America hold a considerable share in the global stem cell therapy market. The rising public-private funding and research grants for developing safe and effective stem cell therapy products and the growing number of clinical trials across the US are key factors driving the growth of the market.
Global Stem Cell Therapy Market Growth, by Region 2022-2028
Asia-Pacific to Exhibit Considerable Growth in the Global Stem Cell Therapy Market
The growing awareness among the population regarding the advantages of stem cell therapies is contributing to the regional market growth. The government of India has conducted stem cell research through various Departments/ Institutions by supporting basic as well as clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT) and Department of Science and Technology (DST). ICMR has released the National Guidelines for Stem Cell Research (NGSCR) 2017 which were framed in the harmonization of international guidelines. The government has supported the ethical and scientific conduct of stem cell research through guidelines for stem cell research. The ICMR invested INR 43,619,531; INR 6,882,564; and INR 30,834,008 in 2019; 2020; and 2021 respectively under Stem cell research in fellowships and Ad-hoc project.
The Department of Biotechnology (DBT) supported projects for basic biology of stem cells; early and late translational research; development of gene editing technology for potential therapeutic applications and the creation of animal models for various human diseases. The funds released by the DBT during the last three years and the current year in this area are nearly $9.2 million.
Market Players Outlook
The major companies serving the global stem cell therapy market include Smith & Nephew plc, MEDIPOST Co., Ltd., and Anterogen Co., Ltd., among others. The companies are focusing on product innovation, mergers & acquisitions, and finding a new market or innovation in their core competency to expand individual market share.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global stem cell therapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Stem Cell Therapy Market, By Type
4.1.1. Allogeneic
4.1.2. Autologous
4.2. Global Stem Cell Therapy Market, By Therapeutic Application
4.2.1. Musculoskeletal
4.2.2. Wound & Injury
4.2.3. CVD
4.2.4. Autoimmune & Inflammatory
4.3. Global Stem Cell Therapy Market, By Cell Source
4.3.1. Adipose Tissues
4.3.2. Bone Marrow
4.3.3. Placenta/Umbilical Cord
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Anterogen Co., Ltd.
6.2. JCR Pharmaceuticals Co., Ltd.
6.3. MEDIPOST Co., Ltd.
6.4. NuVasive, Inc.
6.5. PHARMICELL Co., Ltd.
6.6. Smith & Nephew plc
1. GLOBAL STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL AUTOLOGOUS STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL STEM CELL THERAPY FOR MUSCULOSKELETAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL STEM CELL THERAPY FOR WOUND & INJURY MARKET RESEARCH, AND ANALYSIS BY
7. REGION, 2021-2028 ($ MILLION)
8. GLOBAL STEM CELL THERAPY FOR CVD MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL STEM CELL THERAPY FOR AUTOIMMUNE & INFLAMMATORY MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY CELL SOURCE, 2021-2028 ($ MILLION)
11. GLOBAL ADIPOSE TISSUES BASED STEM CELL THERAPY MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL BONE MARROW BASED STEM CELL THERAPY MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL PLACENTA/UMBILICAL CORD BASED STEM CELL THERAPY MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. NORTH AMERICAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. NORTH AMERICAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
17. NORTH AMERICAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY CELL SOURCE, 2021-2028 ($ MILLION)
18. EUROPEAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. EUROPEAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. EUROPEAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
21. EUROPEAN STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY CELL SOURCE, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY CELL SOURCE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. REST OF THE WORLD STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
29. REST OF THE WORLD STEM CELL THERAPY MARKET RESEARCH AND ANALYSIS BY CELL SOURCE, 2021-2028 ($ MILLION)
1. GLOBAL STEM CELL THERAPY MARKET SHARE BY TYPE, 2021 VS 2028 (%)
2. GLOBAL STEM CELL THERAPY MARKET SHARE BY THERAPEUTIC APPLICATION, 2021 VS 2028 (%)
3. GLOBAL STEM CELL THERAPY MARKET SHARE BY CELL SOURCE, 2021 VS 2028 (%)
4. GLOBAL STEM CELL THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
5. GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL AUTOLOGOUS STEM CELL THERAPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL STEM CELL THERAPY FOR MUSCULOSKELETAL MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL STEM CELL THERAPY FOR WOUND & INJURY MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL STEM CELL THERAPY FOR CVD MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL STEM CELL THERAPY FOR AUTOIMMUNE AND INFLAMMATORY MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL ADIPOSE TISSUE BASED STEM CELL THERAPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL BONE MARROW BASED STEM CELL THERAPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. GLOBAL PLACENTA/UMBILICAL CORD BASED STEM CELL THERAPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. GLOBAL STEM CELL THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL STEM CELL THERAPY MARKET SHARE BY THERAPEUTIC APPLICATION, 2021 VS 2028 (%)
16. GLOBAL STEM CELL THERAPY MARKET SHARE BY TYPE, 2021 VS 2028 (%)
17. INDIA STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
19. JAPAN STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
21. REST OF EUROPE STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF THE WORLD STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
24. SPAIN STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
25. UK STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
26. US STEM CELL THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
